Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study

201964 citationsJournal Articlegold Open Access

Authors

Nirmish Shah · Duke University

Menaka Bhor · Novartis (United States)

Lin Xie

Rashid Halloway · Novartis (United States)

Steve Arcona · Novartis (United States)

Jincy Paulose · Novartis (United States)

Hüseyin Yüce · New York City College of Technology

Abstract

Overall, the study showed the patients had significant unmet needs manifest as poor medication adherence, high treatment discontinuation rates, and high economic burden.

Topics & Keywords

Hemoglobinopathies and Related Disorders Iron Metabolism and Disorders Myeloproliferative Neoplasms: Diagnosis and Treatment

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Health and Quality of Life Outcomes

Volume 17, Issue 1, pp. 155-155

DOI: 10.1186/s12955-019-1225-7

Field-Weighted Citation Impact: 4.70